Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal CancerNaohiro Tomita, Shigeki Sekine, Yuko Kawasaki et al.|International Journal of Clinical Oncology|2021Cited by 157
Influence of age and comorbidity on prognosis and application of adjuvant chemotherapy in elderly Japanese patients with colorectal cancer: A retrospective multicentre studyTomoki Yamano, Yoshito Akagi, Kenichi Hakamada et al.|European Journal of Cancer|2017Cited by 63
Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trialJunichi Koike, Shingo Kameoka, Takeshi Yamada et al.|Cancer Chemotherapy and Pharmacology|2017Cited by 50
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (Translated Version)Hideyuki Ishida, Osamu Tsuruta, Shigeki Sekine et al.|Journal of the Anus Rectum and Colon|2018Cited by 47